【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Type 2 Diabetes 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Type 2 Diabetes to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Type 2 Diabetes to Metabolic Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Type 2 Diabetes 26
Subjects Recruited Over a Period of Time 56
Clinical Trials by Sponsor Type 57
Prominent Sponsors 58
Top Companies Participating in Type 2 Diabetes Therapeutics Clinical Trials 59
Prominent Drugs 61
Latest Clinical Trials News on Type 2 Diabetes 62
May 15, 2014: Transition Therapeutics Diabetes Drug Candidate, TT-401, Commences Phase 2 Clinical Study 62
May 14, 2014: Isis Pharmaceuticals Reports Phase 2 Data on ISIS-GCGR Rx Showing Significant Reduction in HbA1c in Patients With Type 2 Diabetes 62
May 13, 2014: AstraZeneca announces positive results from Phase III study of saxagliptin/dapagliflozin combination in patients with type 2 diabetes inadequately controlled on metformin and outlines future development plans for the oral antidiabetic franchise 63
May 12, 2014: Xenetic Biosciences Announces Positive Phase 1 Clinical Results for PSA-Oxyntomodulin for the Treatment of Type II Diabetes and Obesity 64
May 12, 2014: Lilly’s Basal Insulin Peglispro Shows Superiority in HbA1c Reduction Compared to Insulin Glargine in Three Phase III Trials in Patients with Type 2 Diabetes 65
May 01, 2014: Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx in Patients With High Triglycerides and Type 2 Diabetes 66
Apr 24, 2014: Oramed Pharmaceuticals Presents Data from Phase IIa Trial with ORMD-0801 in Type 2 Diabetes at the 2014 Diabetes Summit 67
Apr 16, 2014: Islet Sciences Announces Positive 12-Week Phase 2 Clinical Results for SGLT2 Inhibitor Remogliflozin Etabonate 68
Apr 09, 2014: Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone Lispro 68
Apr 03, 2014: ProMetic’s PBI-4050 Shown to Reduce Blood Glucose and Kidney Fibrosis in Preclinical Models of Human Type II Diabetes and Kidney Disease 70
Mar 30, 2014: Higher risks without cardio benefits halt study of aleglitazar 71
Mar 19, 2014: Hua Medicine’s Novel Glucokinase Activator Reports Positive Phase 1a Data Demonstrating Robust Glucose Regulatory Hormone Modulation & Commences Phase 1b Trials in Diabetes Patients 71
Mar 17, 2014: Theracos Reports Positive Outcomes from a 96-Week Phase 2 Study of THR1442, a Highly Specific SGLT2 Inhibitor, for the Treatment of Type 2 Diabetes 72
Mar 10, 2014: Fibrotech announces positive Phase Ia results for anti-fibrotic FT011 73
Mar 04, 2014: Boston Therapeutics to Initiate a Phase II Clinical Study of BTI-320 in U.S. 73
Mar 04, 2014: Novo Nordisk Successfully Completes Phase I Trial of its Proprietary Oral Insulin using Merrion Pharmaceuticals’ GIPET Technology. 74
Clinical Trial Profiles 75
Clinical Trial Overview of Top Companies 75
Novo A/S 75
Clinical Trial Overview of Novo A/S 75
Eli Lilly and Company 103
Clinical Trial Overview of Eli Lilly and Company 103
Bristol-Myers Squibb Company 121
Clinical Trial Overview of Bristol-Myers Squibb Company 121
Merck & Co., Inc. 139
Clinical Trial Overview of Merck & Co., Inc. 139
Sanofi 154
Clinical Trial Overview of Sanofi 154
Novartis AG 166
Clinical Trial Overview of Novartis AG 166
AstraZeneca PLC 179
Clinical Trial Overview of AstraZeneca PLC 179
GlaxoSmithKline plc 191
Clinical Trial Overview of GlaxoSmithKline plc 191
Takeda Pharmaceutical Company Limited 201
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 201
Pfizer Inc. 211
Clinical Trial Overview of Pfizer Inc. 211
Clinical Trial Overview of Top Institutes / Government 220
The National Institute of Diabetes and Digestive and Kidney Diseases 220
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 220
Tehran University of Medical Sciences 223
Clinical Trial Overview of Tehran University of Medical Sciences 223
Juntendo University School of Medicine 226
Clinical Trial Overview of Juntendo University School of Medicine 226
Maastricht University Medical Center 228
Clinical Trial Overview of Maastricht University Medical Center 228
U.S. Department of Veterans Affairs 230
Clinical Trial Overview of U.S. Department of Veterans Affairs 230
Aarhus University 232
Clinical Trial Overview of Aarhus University 232
National Heart, Lung, and Blood Institute 234
Clinical Trial Overview of National Heart, Lung, and Blood Institute 234
Washington University School of Medicine 236
Clinical Trial Overview of Washington University School of Medicine 236
Vanderbilt University 237
Clinical Trial Overview of Vanderbilt University 237
Academic Medical Center 238
Clinical Trial Overview of Academic Medical Center 238
Five Key Clinical Profiles 240
Appendix 317
Abbreviations 317
Definitions 317
Research Methodology 318
Secondary Research 318
About GlobalData 319
Contact Us 319
Disclaimer 319
Source 319
【レポート販売概要】
■ タイトル：2型糖尿病：グローバル臨床試験レビュー（2014年上半期）■ 英文：Type 2 Diabetes Global Clinical Trials Review, H1, 2014
■ 発行日：2014年5月30日
■ 調査会社：GlobalData
■ 商品コード：GDHC2185CTIDB
■ 調査対象地域：グローバル
- 上肢痙縮：治療薬の治験動向（2014年下半期）Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Upper Limb Muscle Spasticity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Upper Limb Muscle Spasticity. It includes an overview …
- ホルムアルデヒドの世界市場：ホルムアルデヒド樹脂、アセタール樹脂、BDO、MDI、ペンタエリトリトール用途About Formaldehyde Formaldehyde is one of the most significant industrial aldehydes used to carry out catalytic oxidation of methanol. Manufacturers use formaldehyde to manufacture formaldehyde resins and other downstream products such as acetal resins, BDO, MDI, and pentaerythritol. It is mostly produced and supplied as formalin, the 37 percent aqueous solution of formaldehyde. Methanol acts as a …
- 産業用クリーニングの世界市場予測：界面活性剤、溶媒、キレート剤Increasing demand from applications is expected to drive the industrial cleaning chemicals marketThe global industrial cleaning chemicals market size is estimated to grow from USD 46.8 billion in 2019 to USD 58.2 billion by 2024, at a CAGR of 4.5%. The industrial cleaning chemicals industry is mainly driven by the increasing demand from various applications, including manufacturing, healthcare, re …
- 食品着色料の世界市場：製品別（合成、天然、NI（Nature Identical）、キャラメル）、用途別（非乳製品、乳製品、アルコール飲料、CSD・非アルコール飲料）、地域別予測Global Food Colors Market to reach USD 3.01 billion by 2025. Global Food Colors Market valued approximately USD 1.81 billion in 2016 is forecasted to grow with a healthy growth rate of more than 5.82% over the forecast period 2018-2025. The market growth is primarily attributed to the increase in global population which is anticipated to result in risen needs for food & beverage products. Food col …
- ヒューズホルダーの世界市場2016-2020About Fuse Holder Fuse holders are electronic devices that are used for containing, mounting, and protecting fuses. Fuse holders basically come in two types: open and fully enclosed. Open fuse holders are fuse blocks, clips, plug-in caps, and socket varieties. Fully enclosed fuse holders use a fuse carrier, which is inserted into the holder or some other part to fully enclose the fuse. Technavio’s …
- 世界の仮想デスクトップインフラ市場：Global Virtual Desktop Infrastructure (VDI) Market 2014-2018TechNavio's analysts forecast the Global Virtual Desktop Infrastructure market to grow at a CAGR of 9.04 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need for remote access interfaces. The Global Virtual Desktop Infrastructure market has also been witnessing the growing adoption of cloud-based virtual desktop infrastructure solutions. However, …
- 迅速検査サービスの世界市場予測（～2022年）：技術、汚染物質、食品The global market for rapid test has grown exponentially in the last few years. The market size is projected to reach USD 15.71 Billion by 2022, growing at a CAGR of around 7.7% from 2017. Emerging countries such as India, China, India, Brazil, and Argentina are the potential primary markets of the industry. Factors such as rising demand for rapid test result to enhance productivity, increasing fo …
- カラーコンセントレートの世界市場予測（～2021）The color concentrates market is projected to reach USD 5.80 Billion by 2021, at a CAGR of 6.5% from 2016 to 2021. The color concentrates market has witnessed high growth in the recent years, and this growth is projected to continue in the near future, owing to increase in demand for color concentrates in various end-use industries, such as packaging, consumer goods, building & construction, and a …
- 流量センサの世界市場2015-2019About Flow Sensors Flow sensors are used for measuring the flow of liquids, slurries, viscous media, gases, air, steam, and bulk solid materials. The device constitutes indicator, scale, top, and tube. The sensitivity varies depending on different characteristics of the fluid, like density, pressure, temperature, and viscosity. The performance of the flow sensor is measured based on parameters, su …
- 老年医学の世界市場分析：分類別（鎮痛薬、抗高血圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬）、治療条件別（心臓血管、関節炎、神経学、がん、骨粗鬆症、呼吸器）、セグメント予測The global geriatric medicine market is expected to reach over USD 1,017 billion by 2024 according to a new report by Grand View Research Inc. Increase in the global geriatric population is one of the major challenges for the healthcare industry and the governments across the globe, however, it has proven to be a boon for the geriatric medicine market. The high market growth is anticipated on acco …
- 脂肪代替品の世界市場分析：製品別（炭水化物、タンパク質、脂肪）、用途別（ベーカリー･菓子類、酪農･冷凍デザート、飲料、加工肉、ドレッシング、マーガリン･スプレッド、即席食品）、地域別、セグメント予測、2014-2025The global fat replacers market is anticipated to reach USD 2.79 billion by 2025, according to a new report by Grand View Research, Inc. Growing food processing industry coupled with a trend of maintaining nutritionally balanced lifestyle is expected to augment market growth over the coming years. The ability of the fat replacer to mimic the physical and chemical qualities of lipids, thereby, prov …
- 低煙ハロゲンフリー難燃性ポリプロピレン（PP）の世界市場分析：用途別（建設、自動車、電気・電子、工業用）、セグメント予測The global low smoke halogen free flame retardant polypropylene (PP) market is expected to reach USD 893.9 million by 2024, according to a new report by Grand View Research, Inc. The increasing construction spending particularly in emerging economies is one of the major reason fueling the market growth. Favorable government regulations are further anticipated to benefit the overall market. The gov …
- 肥料散布機の世界市場2016-2020About the Fertilizer Spreader Market The market is driven by factors like the need for increased accuracy in spreading fertilizers. As a result of improper application of fertilizers, farmers bear significant business losses due to uneven growth in crops and poor yield. Labor scarcity and increased government support to purchase agricultural equipment will also help the market grow over the next f …
- アメリカの試験準備サービス市場2016-2020About the Test Preparation Market The benchmarking in the education system is highly useful in measuring the performance of students, teachers, and schools. The test preparation industry has emerged alongside with the extensive standardization of the education sector in the US. This standardization essentially refers to the provision of exam preparation services to students to help them score well …
- 融資処理の世界市場2017-2021About Loan ServicingLoan servicing software functions as a complete loan servicing system, transaction processing and banking, investor accounting, collection management system, credit reporting software, and electronic funds automated clearing house (ACH) payments and collections. The pricing of loan servicing software is dependent upon the volume, complexity, essential features, and exact requir …
